Highlights UnitedHealth Group Inc.

Equities

UNH

US91324P1021

Managed Healthcare

Market Closed - Nyse Other stock markets 16:00:02 2026-03-10 EDT			5-day change	1st Jan Change
282.34 ^USD	-0.99%		-2.38%	-14.47%

03-10	Wolfe Research Adjusts Price Target on UnitedHealth to $350 From $400, Maintains Outperform Rating	MT
03-09	Investors Confront Stagflation Risk

Highlights

03-09	Investors Confront Stagflation Risk
03-08		FA
02-25	UnitedHealth Group Incorporated Authorizes Payment of Quarterly Dividend, Payable on March 17, 2026	CI
02-25	UnitedHealth Group Keeps Quarterly Dividend at $2.21 a Share, Payable March 17 to Shareholders of Record as of March 9	MT
02-17	Palo Alto Networks cuts annual profit forecast as deal costs bite, shares fall	RE
02-17	PRESS DIGEST-Wall Street Journal - February 17	RE
02-11	Humana forecasts downbeat 2026 profit on hit from lower Medicare star ratings	RE
02-10	CVS Health keeps in place 2026 forecast, eyes topping it	RE
02-06	Luigi Mangione faces June 8 trial in state case over CEO killing	RE
02-06	Centene sees 2026 profit above estimates signaling stabilizing costs	RE
02-05	Molina Healthcare forecasts 2026 profit below estimates as costs weigh; shares slide	RE
02-05	Cigna beats quarterly estimates, provides muted outlook	RE
02-05	Cigna 2026 forecast misses Wall Street expectations	RE
02-04	Cigna settles FTC insulin case, aims to lower drug prices	RE
02-04	Cigna settles FTC insulin case, aims to lower drug prices	RE
02-04	Cigna settles FTC insulin case, commits to overhauling drug pricing	RE
02-04	Wegovy Maker Novo Nordisk's Shares Slump After Guidance Disappoints	DJ
02-03	Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business	RE
01-30	Luigi Mangione will not face death penalty after US judge dismisses murder charge	RE
01-30	The Fed's Next Chair: Reformist, Realist, or Rubber Stamp?
01-29	Health Care Up Amid Defensive Bias -- Health Care Roundup	DJ
01-28	UnitedHealth Group's 2026 Outlook Steady as Medicare Advantage Rate Raises Uncertainty, Morgan Stanley Says	MT
01-28	Elevance Health: sees profit decline in 2026 as medical cost pressures mount
01-28	Franchise Brands intends share buyback as sales rise in 2025	AN
01-28	Elevance forecasts 2026 profit below estimates, flags revenue decline	RE